e-learning
resources
European Respiratory Review
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Rare pulmonary disease and orphan drugs: a path to the future
Sergio Harari, Yochai Adir, Marc Humbert
Source:
Eur Respir Rev, 28 (153) 190115; 10.1183/16000617.0115-2019
Journal Issue:
September
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sergio Harari, Yochai Adir, Marc Humbert. Rare pulmonary disease and orphan drugs: a path to the future. Eur Respir Rev, 28 (153) 190115; 10.1183/16000617.0115-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Bronchiectasis in patients with alpha1-antitrypsin deficiency: prevalence and characteristics
Role of HGF in the healthy and injured lung
Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early Spanish experience with the European Named patient program (NPP)
Related content which might interest you:
Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
Source: Eur Respir Rev 2015; 24: 375-377
Year: 2015
Toward better management of rare and orphan pulmonary diseases
Source: Eur Respir J 2016; 47:1334-1335
Year: 2016
Treatment of lymphangioleiomyomatosis: building evidence in orphan diseases
Source: Eur Respir J 2014; 43: 966-969
Year: 2014
Rare pulmonary diseases: a common fight
Source: Eur Respir Rev, 26 (145) 170059; 10.1183/16000617.0059-2017
Year: 2017
Chronic post-embolic pulmonary hypertension: a new target for medical therapies?},
Source: Eur Respir Rev 2013; 22: 258-264
Year: 2013
Fibrocytes: potential new therapeutic targets for pulmonary hypertension?
Source: Eur Respir J 2010; 36: 1232-1235
Year: 2010
Rare and orphan lung diseases
Source: ISSN=ISSN 1810-6838, ISBN=, page=146
Year: 2005
Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential
Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017
Year: 2017
Monitoring of pulmonary function in Pompe disease: a muscle disease with new therapeutic perspectives
Source: Eur Respir J 2005; 26: 984-985
Year: 2005
The effectiveness of anti-inflammatory therapy for chronic obstructive pulmonary disease complicated by ischemic heart disease (new medication - new opportunities)
Source: International Congress 2014 – Comorbidities
Year: 2014
Atypical mycobacteriosis : new drugs, new strategies
Source: Annual Congress 2004 - PG11 - Multiresistant tuberculosis and atypical mycobacterial disease
Year: 2004
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
Source: Eur Respir J 2015; 46: 243-249
Year: 2015
Combined emphysema & interstitial pulmonary disease. A new disease entity?
Source: Eur Respir J 2002; 20: Suppl. 38, 587s
Year: 2002
Interstitial lung disease: new challenges and evolving phenotypes
Source: Eur Respir Rev 2009; 19: 91-93
Year: 2010
To be or not to be–could it be drug related pulmonary disease?
Source: International Congress 2014 – PG02 Current clinical problems in pulmonology
Year: 2014
Global effort against rare and orphan diseases
Source: Eur Respir Rev 2012 21:171-172
Year: 2012
Global effort against rare and orphan diseases
Source: Annual Congress 2013 –European Respiratory Review: what's hot in pulmonary medicine
Year: 2013
Chronic thromboembolic pulmonary hypertension: do we need a new definition?
Source: Eur Respir J 2014; 44: 1401-1403
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept